DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Talaporfin is an investigational drug.
There have been 12 clinical trials for Talaporfin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Liver Neoplasms, Neoplasms, and Hyperplasia. The leading clinical trial sponsors are Light Sciences Oncology, Light Sciences LLC, and Children's Hospital of Philadelphia.
Recent Clinical Trials for Talaporfin
|A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia||Mundipharma Research Limited||Phase 2|
|A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia||Light Sciences Oncology||Phase 2|
|Novel Treatment for Port Wine Stain Birthmarks||Beckman Laser Institute University of California Irvine||Phase 1|